# A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

> **NCT03236233** · PHASE1 · COMPLETED · sponsor: **Pulmocide Ltd** · enrollment: 39 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **DRUG:** PC786 - Single doses
- **DRUG:** Placebo - Single doses
- **DRUG:** PC786 - Repeat doses
- **DRUG:** Placebo - Repeat doses

## Key facts

- **NCT ID:** NCT03236233
- **Lead sponsor:** Pulmocide Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-21
- **Primary completion:** 2017-12-15
- **Final completion:** 2017-12-15
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236233, "A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03236233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*